ASXL1 alteration cooperates with JAK2V617F to accelerate myelofibrosis

Ying Guo, Yuan Zhou, Shohei Yamatomo, Hui Yang, Peng Zhang, Shi Chen, Stephen D. Nimer, Zhizhuang Joe Zhao, Mingjiang Xu, Jie Bai, Feng Chun Yang

Research output: Contribution to journalLetter

7 Scopus citations
Original languageEnglish (US)
Pages (from-to)1287-1291
Number of pages5
JournalLeukemia
Volume33
Issue number5
DOIs
StatePublished - May 1 2019

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Guo, Y., Zhou, Y., Yamatomo, S., Yang, H., Zhang, P., Chen, S., Nimer, S. D., Zhao, Z. J., Xu, M., Bai, J., & Yang, F. C. (2019). ASXL1 alteration cooperates with JAK2V617F to accelerate myelofibrosis. Leukemia, 33(5), 1287-1291. https://doi.org/10.1038/s41375-018-0347-y